Data as of Dec 19
| +0.03 / +0.67%|
The 2 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +56.25% increase from the last price of 4.48.
The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.